Vaspin, human recombinant protein
Serpin A12 precursor, Visceral adipose-specific serpin, Visceral adipose tissue- derived serine prot
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q8IW75 |
---|---|
Concentration | 1 |
Calculated MW | 47.0 kDa |
Gene ID | 145264 |
---|---|
Gene Symbol | SPA12 |
Other Names | Serpin A12 precursor, Visceral adipose-specific serpin, Visceral adipose tissue- derived serine protease inhibitor, Vaspin, OL-64, SERPINA12, Serine (or cysteine) proteinase inhibitor, clade A, antitrypsin, α-1 antiproteinase, |
Gene Source | Human |
Source | E. coli |
Assay&Purity | SDS-PAGE; ≥98% |
Assay2&Purity2 | HPLC; ≥90% |
Recombinant | Yes |
Application Notes | Centrifuge the vial prior to opening. Reconstitute in water to a concentration of 0.1-1.0 mg/ml. Do not vortex. |
Format | Lyophilized protein |
Storage | -20°C; Lyophilized from 50 mM Tris, pH 7.5 + 150 mM NaCl. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Vaspin (visceral adipose-specific SERPIN), a newly identified adipokine, is a member of serine protease inhibitor family. Vaspin is also a unique insulin sensitizing adipocytokine in obesity. A recent publication indicates that induction of human vaspin mRNA expression in adipose tissue is regulated in a fat depot-specific manner and could be associated with parameters of obesity, insulin resistance, and glucose metabolism. Recombinant human Vaspin produced in E.Coli is a single, non-glycosylated polypeptide chain containing 415 amino acids and having a molecular mass of 47 kDa.
References
Hida K.,et al.Proc. Natl. Acad. Sci. U.S.A. 102:10610-10615(2005).
Chen S.,et al.Submitted (NOV-2002) to the EMBL/GenBank/DDBJ databases.
Heiker J.T.,et al.Cell. Mol. Life Sci. 70:2569-2583(2013).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.